Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Mar 01, 2008 (Vol. 28, No. 5)

Scitizen

URL:scitizen.com/
  • Well organized, topical
  • None
I have to say that I really like the title of this site and I wish I’d thought it up. Scitizen’s subtitle is “Bringing Science Closer to Society” and I can’t think of a more aptly named site. With a format best described as open news source (contributions are welcomed from everyone), the opening page is not unlike a newspaper, with headlines and story lead-ins below that hyperlink to outside articles. The topics that are covered span a wide range of the biological sciences, including technology, biology, and environmental sciences. Sub-categories, include stem cells, biodiversity, future energies, climate change, and more. To be a contributor requires users to register at the site, but that is not at all uncommon for sites of with this sort of content. I found the quality of articles (some of which are YouTube videos) to be outstanding and their topicality cannot be doubted. An outstanding site that I will keep bookmarked on my computer.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »